Saltar al contenido
Merck

Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine.

Journal of the American Society of Nephrology : JASN (1994-08-01)
D S Alejandro, J Petersen
RESUMEN

Acute renal failure can occur in cardiac transplant patients for a variety of reasons. A case of a patient who developed acute renal failure secondarily to drug-induced rhabdomyolysis is reported. The literature regarding acute renal failure and lovastatin and other 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors is reviewed. The potential mechanisms of myoglobinuria and nephrotoxicity and the therapeutic implications are discussed.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Mevinolin from Aspergillus sp., ≥98% (HPLC)
USP
Lovastatin, United States Pharmacopeia (USP) Reference Standard
Supelco
Lovastatin, Pharmaceutical Secondary Standard; Certified Reference Material
Lovastatin, European Pharmacopoeia (EP) Reference Standard
Lovastatin for peak identification, European Pharmacopoeia (EP) Reference Standard